Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Mometasone Furoate EP Impurity A | C27H29ClO5 | 83880-65-3 | Details |
| 3-(2-Chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (Paliperidone) | C11H11ClN2O2 | 260273-82-3 | Details |
| Granisetron Impurity 4 | C17H22N4O | 160177-67-3 | Details |
| 6-Hydroxy chlorzoxazone | C7H4ClNO3 | 1750-45-4 | Details |
| Domperidone EP Impurity B | C13H14ClN3O2 | 1346598-11-5 | Details |
| Apixaban Impurity C | C26H27N5O4 | 2098457-92-0 | Details |
| Midazolam EP Impurity H | C15H10ClFN2 | 119401-13-7 | Details |
| Etoricoxib Impurity 15 | C5H8ClNO | 73312-69-3 | Details |
| 1,6-NAPHTHYRIDINE-3-CARBOXAMIDE, 4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-1,4-DIHYDRO-2,8-DIMETHYL-, (4R)- | C21H22N4O3 | 1050477-30-9 | Details |
| Ivermectin | C48H74O14 | 70288-86-7 | Details |
| (2S)-2-Aminobutanedioic acid ditert-butyl ester | C12H23NO4 | 13795-73-8 | Details |
| Doxofylline Impurity 3 | C11H14N4O4 | 1174289-18-9 | Details |
| CDP-065-imp R | C16H19N3O5 | 1429334-00-8 | Details |
| 2,3,5-trimethyl-6-nitro-1-oxidopyridin-1-ium | C8H10N2O3 | Details |
| Omeprazole Impurity 34 | C26H30N4O3S | 1346600-29-0 | Details |
| (3R, 4R) -3-ethyl-4-(3h-imidazole [1,2-a ]1H-pyrrole [2,3-e ] pyrazine-8-yl)-n-(2,2,2-trifluoroethyl) pyrrolidine-1-formamide | C17H19F3N6O | 1310726-59-0 | Details |
| METHYL DODECYLBENZENE SULFONATE | C19H32O3S | 52319-06-9 | Details |
| Ademetionine-1，4-Butanedisulfonate Impurity 5 | C6H14O6S2 | 4239-21-8 | Details |
| N-nitrososarcosine ethyl ester | C5H10N2O3 | 13344-50-8 | Details |
| 3-Ethyl-6,7,8,9-tetrahydro-9-hydroxy-2-Methyl-4H-pyrido[1,2-a]pyriMidin-4-one | C11H16N2O2 | 849903-79-3 | Details |
| diethyl butane-1,4-disulfonate | C8H18O6S2 | 98544-67-3 | Details |
| Cefuroxime Sodium EP Impurity B | C17H17N3O8S | 39685-31-9 | Details |
| GE, IN RE, R, SC standard solution 1 | Details |
| Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- | C29H43N5 | 1648791-23-4 | Details |
| Cefuroxime Sodium EP Impurity C | C15H15N3O6S | 69822-88-4 | Details |
| Cefuroxime Sodium EP Impurity G | C17H17N3O8S | 97232-98-9 | Details |
| Upadacitinib Impurity D | C22H23N5O2 | 2095311-51-4 | Details |
| 2-Methyl-2-thiazoline-4-carboxylic Acid Sodium Salt | C5H6NNaO2S | 15058-19-2 | Details |
| Afatinib Impurity 24 | Details |
| Febuxostat Impurity z2-9 | Details |
| Doxofylline Impurity 2 | C9H10N4O3 | 5614-53-9 | Details |
| IIvabradine R-Isomer HCl | C27H37ClN2O5 | 148849-68-7 | Details |
| Mometasone Furoate EP Impurity T | C32H32Cl2O8 | Details |
| Moxidectin | C37 H53 N O8 | 113507-06-5 | Details |
| [(3s, 4R) -3-ethyl-4-(3h-imidazole [1,2-a ]1H-pyrrole [2,3-e ] pyrazine-8-yl) pyrrolidine-1-yl ](1h-imidazole-1-yl) methyl ketone | Details |
| Cefuroxime Sodium EP Impurity I | C7H10N2O4 | 97148-39-5 | Details |
| Lenvatinib Impurity CDP-082-IMP AC | Details |
| Domperidone EP Impurity C | C22H24ClN5O3 | 118435-03-3 | Details |
| 1-(6-Methylpyridin-3-yl)-2-(4-(Methylthio)phenyl)ethanone | C15H15NOS | 221615-72-1 | Details |
| Melphalan Impurity J | Details |
| ((S)-2-AMINO-4-METHYLSULFANYL-BUTYRIC ACID | C9H19NO2S | 4976-72-1 | Details |
| Paliperidone Impurity 7 | C27H45ClN2O3 | 1415488-05-9 | Details |
| Luliconazole Impurity D | C14H9Cl2N3S2 | 101529-76-4 | Details |
| Avanafil Impurity 46 | C19H24ClN5O3 | 372117-53-8 | Details |
| INDAPAMIDE RELATED COMPOUND A (50 MG) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS) | C16H14ClN3O3S | 63968-75-2 | Details |
| 1-Butanesulfonic acid, 4-hydroxy-, methyl ester | C5H12O4S | 343928-18-7 | Details |
| Avanafil Impurity 48 | C23H24ClN7O4 | 1830294-64-8 | Details |
| Indobufen Impurity | C10H11NO4 | 21762-22-1 | Details |
| 4'-Methylacetophenone | C9H10O | 122-00-9 | Details |
| 800027F-1 | Details |
| 2-[[( 3,5-DIMETHYL-4-( 2,2,2-TRIFLUOROETHOXY) PYRIDINYL)METHYL]THIO] -1H-BENZIMIDAZOL | C17H16F3N3OS | 103602-42-2 | Details |
| (R)-3-(Boc-Amino)piperidine | C10H20N2O2 | 309956-78-3 | Details |
| 4-Hexenoic acid, 3-(aminomethyl)-5-methyl- | C8H15NO2 | 216576-74-8 | Details |
| (R)-9-[2-(DIETHYLPHOSPHONOMETHOXY)PROPYL] ADENINE | C13H22N5O4P | 180587-75-1 | Details |
| Emtricitabine Enantiomer | C8H10FN3O3S | 137530-41-7 | Details |
| Selexipag Impurity | Details |
| 2-[4-(1-METHYLPROPYL)PHENYL]PROPANOIC ACID | C13H18O2 | 64451-76-9 | Details |
| L-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester | C15H30N2O4 | 14529-23-8 | Details |
| Daunorubicin EP Impurity E | C21H20O8 | 28008-51-7 | Details |
| (3s, 4R) -3-ethyl-4-(6ethyl-6h-imidazole [1,2-a ]1H-pyrrole [2,3-e ] pyrazine-8-yl)-n-(2,2,2-trifluoroethyl) pyrrolidine-1-formamide | Details |
| PCI-7517(RRT0.51) Ibrutinib Impurity | Details |
| 7-Ketocholesterol | C27H44O2 | 566-28-9 | Details |
| 2-Isopropyl-5-methyl-2-hexenal | C10H18O | 35158-25-9 | Details |
| Emtricitabine Impurity | C8H9FN2O4S | 145986-11-4 | Details |
| phenyl hydrogen ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate | C15H18N5O4P | 379270-35-6 | Details |
| 2-AMINO-3,4-DIFLUOROBENZALDEHYDE | C7H5F2NO | 1602097-79-9 | Details |
| P-(METHYLTHIO)PHENYLACETONITRILE | C9H9NS | 38746-92-8 | Details |
| Vitamin B6 Impurity 6 | C12H17NO3 | 1385767-86-1 | Details |
| (S)-4-((3-chloro-4-methoxybenzyl)amino)-N-ethyl-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxamide | C20H26ClN5O3 | 2520114-39-8 | Details |
| Linagliptin Impurity 18 | C21H21N7O2 | 2468656-63-3 | Details |
| Lenvatinib Impurity CDP-082-IMP AB | Details |
| Benzenesulfonic Acid Monohydrate | C6H8O4S | 26158-00-9 | Details |
| (NitrosoiMino)bisacetic Acid Diethyl Ester | C8H14N2O5 | 5438-83-5 | Details |
| Midazolam EP Impurity B | C18H13ClFN3 | 59469-74-8 | Details |
| (R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one | C17H14ClFN6O2 | 1239662-46-4 | Details |
| CHLOROSUCCINIC ACID | C4H5ClO4 | 16045-92-4 | Details |
| Linagliptin Impurity 10 | C20H18N6O2 | 1911621-52-7 | Details |
| Olmesartan Impurity D | C48H44N6O6 | 144690-92-6 | Details |
| HA1405-013121 | C9H13NOS | 913555-67-6 | Details |
| Dimethyl thiosine | Details |
| Degradation impurity 2 of salmon calcitonin injection | Details |
| 1-(2-methyl-5-nitro-imidazol-1-yl)propan-2-one | C7H9N3O3 | 31876-69-4 | Details |
| L-Pyroglutamic acid | C5H7NO3 | 98-79-3 | Details |
| CDP-082-SM2-imp H | C6H10O4 | 56766-77-9 | Details |
| Granisetron EP Impurity E | C9H18N2 | 76272-56-5 | Details |
| Palbociclib Impurity | C27H35N7O3 | 571189-65-6 | Details |
| (R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione | C17H17N3O4 | 1985607-70-2 | Details |
| Isopropyl myristate | C17H34O2 | 110-27-0 | Details |
| 2-(1-chloroethyl)pyridine | C7H8ClN | 10445-92-8 | Details |
| Daunorubicin EP Impurity E | C21H20O8 | 125515-17-5 | Details |
| Lenvatinib Impurity CDP-082-IMP X | Details |
| NA | Details |
| HA1405-013126 | C16H19NO3S | 1202707-22-9 | Details |
| (Z)-11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepine-2-carbaldehyde 2,2,2-trifluoroacetate | C20H21NO2 | 2519517-77-0 | Details |
| 2-(2-Chloroethyl)pyridine | C7H8ClN | 16927-00-7 | Details |
| Avanafil Impurity | C21H28ClN5O3 | 2520114-11-6 | Details |
| 2-bromo-4-fluoro-1,1'-biphenyl | C12H8BrF | 53591-98-3 | Details |
| Lenvatinib Impurity CDP-082-SM2-IMP L | Details |
| Tropisetron Hydrochloride Impurity V | Details |
| 800027C-1 | Details |
| Product Total： Product Page： | ||||
| 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 | ||||